INS and colorectal cancer: (3) Subgroup analyses showed that among the high cDDD group, DPP4is use remained a risk factor for colorectal cancer in patients who were less than 65 years old, male, without hyperlipidemia, and did not take metformin, sulfonylureas, and insulin.